Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells

Journal of Dermatological Science

Volumn 54, Issue 2, 2009, Pages 69-75

  Yamazaki, Sayuri ^a   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Dendritic cells; Foxp3+ regulatory T cells

Indexed keywords

ANTIGEN; CD103 ANTIGEN; CD8 ANTIGEN; RETINOIC ACID; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; BONE MARROW; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLONAL ANERGY; DENDRITIC CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INTESTINE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SKIN; SPLEEN;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTEGRIN ALPHA CHAINS; INTESTINES; SKIN; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 63149172076     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.02.001     Document Type: Review

References (56)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
2. Sakaguchi S., Yamaguchi T., Nomura T., and Ono M. Regulatory T cells and immune tolerance. Cell 133 (2008) 775-787
3. Zheng Y., and Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8 (2007) 457-462
4. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist Neil., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
5. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
6. Nieves D.S., Phipps R.P., Pollock S.J., Ochs H.D., Zhu Q., Scott G.A., et al. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy X-linked syndrome. Arch Dermatol 140 (2004) 466-472
7. Halabi-Tawil M., Ruemmele F.M., Fraitag S., Rieux-Laucat F., Neven B., Brousse N., et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 160 (2009) 645-651
8. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
9. high regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174 (2005) 164-173
10. high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178 (2007) 2579-2588
11. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25 (2006) 195-201
12. + regulatory T cells by antigen processing dendritic cells. J Exp Med 198 (2003) 235-247
13. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199 (2004) 1467-1477
14. + regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA 103 (2006) 2758-2763
15. + regulatory T cells. Proc Natl Acad Sci USA 104 (2007) 2821-2826
16. - precursors. Blood 110 (2007) 4293-4302
17. + regulatory T cells. J Immunol 181 (2008) 6923-6933
18. + regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism. J Exp Med 204 (2007) 1757-1764
19. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204 (2007) 1775-1785
20. + regulatory cell activation and function by dendritic cells. Int Immunol 16 (2004) 1769-1780
21. + regulatory T cells including suppressors of alloreactivity. Immunol Rev 212 (2006) 314-329
22. Tarbell K.V., Yamazaki S., and Steinman R.M. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol 18 (2006) 93-102
23. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
24. + T regulatory cells. J Immunol 178 (2007) 4022-4026
25. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol 179 (2007) 4685-4693
26. + regulatory T cells confer infectious tolerance in a TGF-β-dependent manner. J Exp Med 205 (2008) 1975-1981
27. H17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 (2007) 256-260
28. Benson M.J., Pino-Lagos K., Rosemblatt M., and Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204 (2007) 1765-1774
29. Denning T.L., Wang Y.C., Patel S.R., Williams I.R., and Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8 (2007) 1086-1094
30. hi Cells. Immunity 29 (2008) 758-770
31. + dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 205 (2008) 2139-2149
32. Belkaid Y., and Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29 (2008) 362-371
33. Steinman R.M., and Banchereau J. Taking dendritic cells into medicine. Nature 449 (2007) 419-426
34. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7 (2007) 19-30
35. Villadangos J.A., Schnorrer P., and Intrinsic. cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7 (2007) 543-555
36. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V., Trumpfheller C., Yamazaki S., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315 (2007) 107-111
37. + regulatory T cells. Proc Natl Acad Sci USA 105 (2008) 9331-9336
38. 8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449 (2007) 361-365
39. Wang Z., Larregina A.T., Shufesky W.J., Perone M.J., Montecalvo A., Zahorchak A.F., et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 6 (2006) 1297-1311
40. Perruche S., Zhang P., Liu Y., Saas P., Bluestone J.A., and Chen W. CD3-specific antibody-induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells. Nat Med 14 (2008) 528-535
41. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101 (2003) 4862-4869
42. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6 (2005) 1219-1227
43. + regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 204 (2007) 1335-1347
44. + dendritic cells survey the skin in the steady state. J Exp Med 204 (2007) 3133-3146
45. + dendritic cells. J Exp Med 204 (2007) 3147-3156
46. Poulin L.F., Henri S., de Bovis B., Devilard E., Kissenpfennig A., and Malissen B. The dermis contains langerin + dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 204 (2007) 3119-3131
47. Stoitzner P., Tripp C.H., Eberhart A., Price K.M., Jung J.Y., Bursch L., et al. Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 103 (2006) 7783-7788
48. Kaplan D.H., Li M.O., Jenison M.C., Shlomchik W.D., Flavell R.A., and Shlomchik M.J. Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells. J Exp Med 204 (2007) 2545-2552
49. Loser K., Mehling A., Loeser S., Apelt J., Kuhn A., Grabbe S., et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12 (2006) 1372-1379
50. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 7 (2006) 652-662
51. Sharma M.D., Baban B., Chandler P., Hou D.Y., Singh N., Yagita H., et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2 3-dioxygenase. J Clin Invest 117 (2007) 2570-2582
52. Chen W., Liang X., Peterson A.J., Munn D.H., and Blazar B.R. The indoleamine 2 3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 181 (2008) 5396-5404
53. Goubier A., Dubois B., Gheit H., Joubert G., Villard-Truc F., Asselin-Paturel C., et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29 (2008) 464-475
54. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., and Butcher E.C. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 9 (2008) 1253-1260
55. + regulatory T cells in human thymus. Nature 436 (2005) 1181-1185
56. Sato K., Yamashita N., Baba M., and Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18 (2003) 367-379